ProCE Banner Activity

Phase III Trial of Rd Followed by R vs Continuous Rd in Intermediate-Fit Elderly Patients With Newly Diagnosed Multiple Myeloma

Slideset Download
Conference Coverage
Using frailty-adjusted Rd followed by R maintenance prolonged EFS compared with continuous Rd in older intermediate-fit patients with newly diagnosed myeloma.

Released: December 11, 2018

Expiration: December 10, 2019

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie

AstraZeneca

Celgene

Dova Pharmaceuticals

Gilead Text

Incyte

Janssen Biotech Pharmacyclics Abbvie

Jazz Pharmaceuticals Inc

Novartis Pharmaceuticals Corporation

Seagen

Takeda Oncology